Literature DB >> 8445833

Non-medical factors that impact on ESRD modality selection.

A R Nissenson1, S S Prichard, I K Cheng, R Gokal, M Kubota, R Maiorca, M C Riella, J Rottembourg, J H Stewart.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8445833

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN： 0098-6577            Impact factor:   10.545


× No keyword cloud information.
  22 in total

Review 1.  Epidemiology of peritoneal dialysis: a story of believers and nonbelievers.

Authors:  Norbert Lameire; Wim Van Biesen
Journal:  Nat Rev Nephrol       Date:  2009-12-15       Impact factor: 28.314

Review 2.  Peritoneal dialysis and the process of modality selection.

Authors:  Peter G Blake; Robert R Quinn; Matthew J Oliver
Journal:  Perit Dial Int       Date:  2013 May-Jun       Impact factor: 1.756

Review 3.  A review of quality of life in chronic renal failure.

Authors:  D S Parsons; D C Harris
Journal:  Pharmacoeconomics       Date:  1997-08       Impact factor: 4.981

Review 4.  The Current State of Peritoneal Dialysis.

Authors:  Rajnish Mehrotra; Olivier Devuyst; Simon J Davies; David W Johnson
Journal:  J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 10.121

5.  Risk of dementia in peritoneal dialysis patients compared with hemodialysis patients.

Authors:  Dawn F Wolfgram; Aniko Szabo; Anne M Murray; Jeff Whittle
Journal:  Perit Dial Int       Date:  2015-03-05       Impact factor: 1.756

6.  Financial effect of clinical decisions: case study of a dialysis center.

Authors:  E A Balas; L L Hicks; J V Stone; L P Ponferrada; D A West
Journal:  J Med Syst       Date:  1995-12       Impact factor: 4.460

7.  Payment Reform and Health Disparities: Changes in Dialysis Modality under the New Medicare Dialysis Payment System.

Authors:  Marc Turenne; Regina Baker; Jeffrey Pearson; Chad Cogan; Purna Mukhopadhyay; Elizabeth Cope
Journal:  Health Serv Res       Date:  2017-05-30       Impact factor: 3.402

Review 8.  Can peritoneal dialysis be used as a long term therapy for end stage renal disease?

Authors:  Michele Giannattasio; Michele Buemi; Flavia Caputo; Giusto Viglino; Enrico Verrina
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

Review 9.  The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care.

Authors:  Braden J Manns; David C Mendelssohn; Kenneth J Taub
Journal:  Int J Health Care Finance Econ       Date:  2007-09

Review 10.  The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies.

Authors:  R L Morton; A Tong; K Howard; P Snelling; A C Webster
Journal:  BMJ       Date:  2010-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.